Assessment of the reduced injection pain of the newly developed formation of the rocuronium
Not Applicable
- Conditions
- Patients requiring general anesthesia
- Registration Number
- JPRN-UMIN000022300
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Muscular disease Known allergy against eslax, propofol Muscle weakness of upper arm Obesity (BMI>30%)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method frequency of the withdrawal response of upper arm 3 minutes after the drug injection.
- Secondary Outcome Measures
Name Time Method magnitude of the withdrawal response, change of blood pressure and heart rate 3 minutes after the drug injection.